Logo image
Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat
Journal article   Open access   Peer reviewed

Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat

B.J. Skelly, D.J. Petrus and P.K. Nicholls
Journal of Small Animal Practice, Vol.44(6), pp.269-272
2003
pdf
hyperadrenocorticism.pdfDownloadView
Author’s Version Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

Hyperadrenocorticism occurs much less frequently in cats than in dogs and, at present, is more difficult to manage successfully. This report documents the use of the steroid synthesis inhibitor trilostane for the treatment of hyperadrenocorticism in a domestic shorthaired cat with pituitary-dependent disease. Although trilostane was able to alleviate the severity of the clinical signs and was well tolerated, the cat subsequently died of renal failure secondary to a fungal infection of the urinary tract.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

567 File views/ downloads
90 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
3 Agriculture, Environment & Ecology
3.232 Veterinary Sciences
3.232.1281 Veterinary Reproductive Health
Web Of Science research areas
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image